Assignment 1: Assessing and Treating Patients With Impulsivity, Compulsivity, and Addiction

Assignment 1: Assessing and Treating Patients With Impulsivity, Compulsivity, and Addiction

Walden University Assignment 1: Assessing and Treating Patients With Impulsivity, Compulsivity, and Addiction-Step-By-Step Guide

This guide will demonstrate how to complete the Walden University Assignment 1: Assessing and Treating Patients With Impulsivity, Compulsivity, and Addiction assignment based on general principles of academic writing. Here, we will show you the A, B, Cs of completing an academic paper, irrespective of the instructions. After guiding you through what to do, the guide will leave one or two sample essays at the end to highlight the various sections discussed below.

How to Research and Prepare for Assignment 1: Assessing and Treating Patients With Impulsivity, Compulsivity, and Addiction                           

Whether one passes or fails an academic assignment such as the Walden University Assignment 1: Assessing and Treating Patients With Impulsivity, Compulsivity, and Addiction depends on the preparation done beforehand. The first thing to do once you receive an assignment is to quickly skim through the requirements. Once that is done, start going through the instructions one by one to clearly understand what the instructor wants. The most important thing here is to understand the required format—whether it is APA, MLA, Chicago, etc.

After understanding the requirements of the paper, the next phase is to gather relevant materials. The first place to start the research process is the weekly resources. Go through the resources provided in the instructions to determine which ones fit the assignment. After reviewing the provided resources, use the university library to search for additional resources. After gathering sufficient and necessary resources, you are now ready to start drafting your paper.

How to Write the Introduction for Assignment 1: Assessing and Treating Patients With Impulsivity, Compulsivity, and Addiction                         

The introduction for the Walden University Assignment 1: Assessing and Treating Patients With Impulsivity, Compulsivity, and Addiction is where you tell the instructor what your paper will encompass. In three to four statements, highlight the important points that will form the basis of your paper. Here, you can include statistics to show the importance of the topic you will be discussing. At the end of the introduction, write a clear purpose statement outlining what exactly will be contained in the paper. This statement will start with “The purpose of this paper…” and then proceed to outline the various sections of the instructions.

How to Write the Body for Assignment 1: Assessing and Treating Patients With Impulsivity, Compulsivity, and Addiction                         

After the introduction, move into the main part of the Assignment 1: Assessing and Treating Patients With Impulsivity, Compulsivity, and Addiction assignment, which is the body. Given that the paper you will be writing is not experimental, the way you organize the headings and subheadings of your paper is critically important. In some cases, you might have to use more subheadings to properly organize the assignment. The organization will depend on the rubric provided. Carefully examine the rubric, as it will contain all the detailed requirements of the assignment. Sometimes, the rubric will have information that the normal instructions lack.

Another important factor to consider at this point is how to do citations. In-text citations are fundamental as they support the arguments and points you make in the paper. At this point, the resources gathered at the beginning will come in handy. Integrating the ideas of the authors with your own will ensure that you produce a comprehensive paper. Also, follow the given citation format. In most cases, APA 7 is the preferred format for nursing assignments.

How to Write the Conclusion for Assignment 1: Assessing and Treating Patients With Impulsivity, Compulsivity, and Addiction                         

After completing the main sections, write the conclusion of your paper. The conclusion is a summary of the main points you made in your paper. However, you need to rewrite the points and not simply copy and paste them. By restating the points from each subheading, you will provide a nuanced overview of the assignment to the reader.

How to Format the References List for Assignment 1: Assessing and Treating Patients With Impulsivity, Compulsivity, and Addiction                           

The very last part of your paper involves listing the sources used in your paper. These sources should be listed in alphabetical order and double-spaced. Additionally, use a hanging indent for each source that appears in this list. Lastly, only the sources cited within the body of the paper should appear here.

Stuck? Let Us Help You

Completing assignments can sometimes be overwhelming, especially with the multitude of academic and personal responsibilities you may have. If you find yourself stuck or unsure at any point in the process, don’t hesitate to reach out for professional assistance. Our assignment writing services are designed to help you achieve your academic goals with ease. 

Our team of experienced writers is well-versed in academic writing and familiar with the specific requirements of the Assignment 1: Assessing and Treating Patients With Impulsivity, Compulsivity, and Addiction assignment. We can provide you with personalized support, ensuring your assignment is well-researched, properly formatted, and thoroughly edited. Get a feel of the quality we guarantee – ORDER NOW. 

Sample Answer for NURS 6630 Assignment 1: Assessing and Treating Patients With Impulsivity, Compulsivity, and Addiction

Impulsivity disorders are characterized by the inability to resist the sudden, powerful desire to do something and difficulties controlling emotions or behaviors. On the other hand, addiction is a complex mental condition characterized by compulsive substance use regardless of detrimental consequences. The purpose of this paper is to describe a patient with an addiction disorder and the treatment interventions.

Introduction to the Case

The case scenario depicts Mrs. Perez, a 53-year-old Puerto Rican woman with alcohol drinking problems since her late teenage years. Perez has been a part of Alcoholics Anonymous from time to time for the last 25 years. The

patient also reports that she has been finding it more difficult to remain sober in the past two years since a casino was opened in her neighborhood. Perez mentions that she gets high when gambling since she takes some drinks when playing high-stake gambling games. However, this leads to increased alcohol consumption and irresponsible gambling. In addition, the client states she has increasingly been smoking in the past two years and is worried about the adverse health impacts.

Mrs. Perez reports that she has tried refraining from alcohol consumption, but gambling makes her high, making her take a few drinks to even up. She has also realized that when she consumes alcohol, she smokes minimally, but she enjoys smoking when gambling. The patient has experienced weight gain from excessive drinking, and her current weight is 122 lbs, having gained 7 lbs. The patient is worried since she borrowed more than $50,000 from her retirement account to pay gambling debts. Noteworthy MSE findings include avoiding eye contact, sad mood, and impaired impulse control. Mrs. Perez is diagnosed with Gambling disorder and alcohol use disorder. The patient factors that may affect decision-making with regard to treatment include age, overall health status, comorbid mental health illnesses, the patient’s previous experience with medication, the patient’s beliefs and opinions on useful therapies, history of treatment compliance, and the patient’s motivation for abstinence.

Decision #1

Vivitrol (naltrexone) injection, 380 mg IM in the gluteal region four-weekly.

Reason for this Decision

Naltrexone was the ideal treatment because it is an FDA-indicated drug for treating alcohol use disorder (AUD). Joshi et al. (2021) explain that naltrexone alleviates alcohol cravings, decreases alcohol consumption, and the monthly injectable formulation helps in compliance. Kranzler and Soyka (2018) explain that naltrexone decreases mesolimbic opioidergic activity, thus controlling the dopamine-mediated rewarding effects of alcohol, resulting in decreased alcohol consumption.

Why Other Decisions Were Not Selected

Disulfiram was not ideal because the physical reaction of alcohol and disulfiram causes dizziness, tachycardia, nausea, flushing, chest pain, and BP changes, which can harm patients, making it less recommended (Joshi et al., 2021). Acamprosate was not selected because it is approved by the FDA to promote abstinence in patients who are abstinent when starting treatment (Kranzler & Soyka, 2018). Mrs. Perez was not abstinent and thus not a suitable candidate for acamprosate therapy.

Click here to ORDER an A++ paper from our MASTERS and DOCTORATE WRITERS: Assignment 1: Assessing and Treating Patients With Impulsivity, Compulsivity, and Addiction

What I Was Hoping To Achieve By Making This Decision

The PMHNP hoped that naltrexone would reduce the patient’s alcohol cravings and excessive consumption (Witkiewitz et al., 2019). Kranzler and Soyka (2018) found that naltrexone effectively reduces the risk of relapse into alcohol and relapse to binge drinking.

Ethical Considerations, Impact on Treatment Plan and Communication

Nonmaleficence impacted the treatment plan since the PMHNP had to select the intervention with the best outcomes and the least side effects. Consequently, naltrexone was chosen for its strong safety profile, and disulfiram was rejected. Respect for autonomy impacted communication with the clinician seeking patient consent to initiate treatment.

Decision #2

Refer the patient to a counselor to address gambling issues.

Reason for this Decision

The patient was referred to a counselor because she had persistent gambling issues that got her into financial problems. Menchon et al. (2018) explain that psychological therapies are the most effective approach for gambling disorders and are connected with marked improvements in the short and the long term. Counseling focuses on the patient, enabling them to search and solve uncertainties, and improving their willingness to change behavior (Ribeiro et al., 2021).

Why Other Decisions Were Not Selected

Adding diazepam to treat anxiety was not ideal because the patient’s anxiety is a likely side effect of naltrexone therapy and thus does not justify medication (Joshi et al., 2021). Chantix was also not added to promote smoking cessation because the smoking problem was linked to gambling, and thus it is important first to solve the gambling issue. Menchon et al. (2018) explain that cognitive behavioral therapy (CBT) facilitates an individual’s understanding of cognitive distortions connected to gambling behavior.

What I Was Hoping To Achieve By Making This Decision

The PMHNP hoped that psychological therapy would help the patient identify cognitive distortions connected with her gambling behavior. Counseling weakens the irrational beliefs, perseveration patterns, and magical thinking associated with the gambling disorder (Menchon et al., 2018). Ribeiro et al. (2021) explain that counseling primarily focuses on the patient’s behavior, cognition, and motivation, thus solving the psychological determinants of gambling.

Ethical Considerations Impact on Treatment Plan and Communication

Beneficence influenced the patient’s treatment since the PMHNP had to refer the patient for counseling to address the gambling issue and promote better health outcomes. Confidentiality impacted communication since the PMHNP had to ensure the patient’s health information was kept confidential and only shared after obtaining the patient’s consent.

Decision #3

Identify the patient’s problems with her counselor, and encourage her to continue attending GA meetings.

Reason for this Decision,

The PMHNP selected this decision because the client reported not liking her counselor, which could affect her adherence to counseling sessions and treatment outcomes. Bolsinger et al. (2020) explain that creating a good therapeutic relationship (TR) in counseling is crucial to improving clinical outcomes, quality of patient care, and patient satisfaction. Kleiven et al. (2020) explain that it is essential for the patient to open up to and connect with personal issues internally, despite this being highly uncomfortable.

Why Other Decisions Were Not Selected

It was not ideal to encourage the patient to continue counseling without addressing the concerns with the counselor because it would have further worsened the therapeutic relationship between Mrs. Perez and the counselor. Kleiven et al. (2020) explain that the TR in psychotherapy is crucial since it facilitates the clients’ ability to approach, acknowledge, and reflect upon challenging issues with sincerity and authenticity. Discontinuing naltrexone was not also ideal because it exhibited efficacy in alleviating alcohol consumption and cravings (Joshi et al., 2021).

What I Was Hoping To Achieve By Making This Decision

The PMHNP hoped that exploring Mrs. Perez’s issues with her counselor would enable her to open up and have an effective relationship with the counselor (Kleiven et al., 2020). Bolsinger et al. (2020) found that a positive TR is connected with better therapy outcomes with regard to clinical improvement, re-hospitalization, and patient satisfaction.

Ethical Considerations Impact on Treatment Plan and Communication

Beneficence affected the treatment plan since the PMHNP had to help the patient identify her issues with the counselor to create a positive TR, promoting better outcomes. Besides, the respect for autonomy affected communication with the client since the PMHNP had to engage the patient to identify the issues with the counselor and address them.

Conclusion

Mrs. Perez was diagnosed with alcohol use disorder and gambling disorder based on her history of excessive alcohol consumption and gambling, which got her in financial trouble. The patient was prescribed Naltrexone injection, 380 mg four weekly, since it reduces alcohol consumption and alcohol cravings (Joshi et al., 2021). Besides, naltrexone is well-tolerated and is not associated with dependence. Disulfiram was not selected because of its disulfiram-alcohol interaction, which causes BP changes, nausea, chest pain, flushing, dizziness, and tachycardia. Acamprosate was not also ideal because it is indicated for patients who have already achieved abstinence (Kranzler & Soyka, 2018).

The patient’s gambling disorder persisted, and the PMHNP referred her for counseling. A psychotherapy approach was the most ideal since it is considered the most treatment for gambling disorders and associated with marked improvements in the short and the long term (Menchon et al., 2018). However, she reported having issues with the counselor, although she participated in gambler anonymous groups. Consequently, the PMHNP sought to examine the client’s issues with her counselor and encouraged her to continue attending GA meetings. This was crucial to maintain a positive TR and ensure the client received the maximum from psychotherapy.

References

Bolsinger, J., Jaeger, M., Hoff, P., & Theodoridou, A. (2020). Challenges and Opportunities in Building and Maintaining a Good Therapeutic Relationship in Acute Psychiatric Settings: A Narrative Review. Frontiers in psychiatry, 10, 965. https://doi.org/10.3389/fpsyt.2019.00965

Joshi, P., Duong, K. T., Trevisan, L. A., & Wilkins, K. M. (2021). Evaluation and Management of Alcohol Use Disorder among Older Adults. Current geriatrics reports, 10(3), 82–90. https://doi.org/10.1007/s13670-021-00359-5

Kleiven, G. S., Hjeltnes, A., Råbu, M., & Moltu, C. (2020). Opening Up: Clients’ Inner Struggles in the Initial Phase of Therapy. Frontiers in Psychology, 11, 591146. https://doi.org/10.3389/fpsyg.2020.591146

Kranzler, H. R., & Soyka, M. (2018). Diagnosis and Pharmacotherapy of Alcohol Use Disorder: A Review. JAMA, 320(8), 815–824. https://doi.org/10.1001/jama.2018.11406

Menchon, J. M., Mestre-Bach, G., Steward, T., Fernández-Aranda, F., & Jiménez-Murcia, S. (2018). An overview of gambling disorder: from treatment approaches to risk factors. F1000Research, 7, 434. https://doi.org/10.12688/f1000research.12784.1

Ribeiro, E. O., Afonso, N. H., & Morgado, P. (2021). Non-pharmacological treatment of gambling disorder: a systematic review of randomized controlled trials. BMC Psychiatry, 21(1), 105. https://doi.org/10.1186/s12888-021-03097-2

Witkiewitz, K., Litten, R. Z., & Leggio, L. (2019). Advances in the science and treatment of alcohol use disorder. Science advances, 5(9), eaax4043. https://doi.org/10.1126/sciadv.aax4043

Sample Answer 2 for NURS 6630 Assignment 1: Assessing and Treating Patients With Impulsivity, Compulsivity, and Addiction

There is a close connection between impulsivity, compulsivity, and addiction. While addiction is defined as a process coordinating the change from an impulsive to compulsive behavior, impulsivity occurs in the early stages of addiction. A person acting impulsively experiences the pleasure of their addiction, and the compulsive aspect would take control when there is a shift causing a person to stay away from their addictions. However, the compulsive behavior would compel a person to participate in their addictions to relieve themselves from the withdrawal effects. The purpose of this paper is to show how to assess and develop a personalized treatment plan for clients with impulsivity, compulsivity, and addiction based on the decision on medications to prescribe to a client, including ethical and legal implications related to the described treatment for clients with impulsivity, compulsivity and addiction.

Introduction to the Case Study

The case in this assignment involves a 53-year-old Puerto Rican female who was administered to the clinic because of an “embarrassing problem” with alcohol addiction in her early 20s when her father passed. The client’s report on being involved in alcoholism is anonymously defined as “on and off” for the past 25 years. The patient also has difficulty in maintaining sobriety which has worsened in the last two years due to her battling with gambling addiction after a casino was opened near her home. This increased the rate of her cigarette smoking, and she is concerned about the negative effect of cigarette smoking on her health.

Decision #1

Initiate the treatment with Naltrexone (Vivitrol) 380mg injection intramuscularly through the gluteal region after every four weeks.

Reason for this Decision

Naltrexone (Vivitrol) is a common description for alcohol addiction, and it works by reducing the amount of alcohol intake by modulating opioid systems. Solli et al. (2018) ascertains that this aids in reinforcing the side effects of alcohol. FDA approved Naltrexone injection in 2006 to address the problem of compliance with oral Naltrexone. The drug is taken monthly instead of taking the daily oral dosage of Naltrexone, that is used to reduce the opportunity of patients discontinuing their medications impulsively.

Why Other Decisions Were Not Selected

Antabuse (Disulfiram) 250 mg orally daily and Campral (Acamprosate) 666 mg orally three times a day are not ideal for this client. These medications are always prescribed for clients who would want to continue abstaining from alcohol. A client taking Antabuse and drinking alcohol may experience adverse side effects such as alcohol toxicity (Mason & Heyser, 2021). This makes this drug not ideal for the client at this time. On the other hand, Campral is not fit for the client because of her weight. She weighs 122lbs which is less than 132lbs. Such patients should take four tablets a day instead of six.

What I Was Hoping to Achieve by Making This Decision

By administering this medication, I hope to decrease the alcohol craving in the patient without letting her go through severe side effects and any future relapses. Naltrexone injection can start working within a few days, but its optimal effect would not be seen until the end of one or two weeks. After four weeks, the client reported to the clinic that she felt wonderful and had not craved alcohol or been in the casino as often since she received her first Naltrexone injection. However, she is concerned that her smoking habit is still persistent and also fights the problem of anxiety and goes to the casino.

Ethical Considerations Impact on Treatment Plan and Communication

Beneficence and patient right to autonomy influence the treatment plan for the patient. I had to select a medication associated with the best outcomes and consequently prescribed Naltrexone injection because there is evidence supporting its efficacy in treating addiction. Besides, I had to seek consent from the patient to initiate treatment.

Decision #2

Refer the client to a counselor to address the gambling issue.

Reason for this Decision

Despite the client responding positively to the given treatment, her gambling addiction is still persistent and needs to be addressed. Therefore, referring her to a counselor is the correct stage to take for the client. Fighting gambling addiction is not easy, but it can be achieved with the help of support groups and treatment programs. The counselor helps the client to identify the underlying cause of pathogenic gambling (Pettorruso et al., 2020). One cause of gambling is living in an environment where gambling is widely practiced and accepted. Such environments increase the chances of a person becoming a compulsive gambler. In this case, the client got hooked on gambling when her friend went to see the new casino that had just been launched. Support groups will allow gamblers to share their feelings and, experiences, strengths, and hope that they may solve their problems collectively. On the other hand, the client reported feeling anxiety as a side effect of the Naltrexone injection. To solve this, the client should be educated on the side effect and allow her body to adjust to the medication.

Why Other Decisions Were Not Selected

Other treatment choices for anxiety, such as Valium (diazepam) 5 mg orally TID/PRN and Chantix (Varenicline) 1 mg orally BID, are not correct now. The client already has addiction treatment, and it would not be wise to add Valium, a long-acting benzodiazepine and highly addictive (Zahid et al., 2018). On the other hand, Chantix could be significant to stop smoking, but the main priority, in this case, is to stop or bring the gambling habit under control.

What I Was Hoping to Achieve by Making This Decision

I am hoping that the client will report positive effects from counseling and support programs. I expect that the client will continue with the current medication of Naltrexone injection with no side effects (Solli et al., 2018). The client returned to the clinic after four weeks reporting that the anxiety was gone, and she met with the counselor. However, she complained that she never liked her counselor but also admitted that she felt supported by the support groups she had joined.

Ethical Considerations Impact on Treatment Plan and Communication

Beneficence and nonmaleficence impacted treatment since I had to select a therapy that would improve the patient’s outcomes without compromising safety. For example, I switched to counseling to enhance the patient’s outcomes and alleviate the side effects of anxiety brought by Naltrexone injection (Pettorruso et al., 2020). Confidentiality impacted communication since I had to assure the patient that the information would be kept confidential and only shared after their consent.

Decision #3

Address the issue that the patient is facing with the counselor and encourage to attend the support group.

Reason for this Decision

At this point, the client is making better progress with the given treatment. However, the issue that the client is facing with the counselor needs to be addressed as it could trigger relapse in the current treatment.

Why Other Decisions Were Not Selected

The other option of discontinuing the Naltrexone injection and encouraging the patient to continue seeing her counselor, and going to the support group program is not appropriate at this time (Pettorruso et al., 2020). The naltrexone injection effect may be invisible for four weeks. Therefore, it is not advisable to discontinue the medication as early as now. It is also imperative that the client be encouraged to attend the support groups while solving the issue between her and the counselor.

What I Was Hoping to Achieve by Making This Decision

I am hoping that the client will continue with her treatment of Naltrexone injection, support group program, and counseling to increase the progress on the treatment plan. Although gambling addiction might be serious, it could be approached by combining various therapeutic modalities to meet a better patient outcome.

Ethical Considerations Impact on Treatment Plan

Beneficence affected treatment since I had to maintain Naltrexone injection, support programs, and counseling since they are associated with better outcomes, and studies support their efficacy in alleviating addiction symptoms. I had to involve the patient in making treatment decisions, which shows respect for autonomy and affects communication.

Conclusion

The 53-year-old Puerto Rican female reports that she had been admitted to the clinic with an embarrassing problem related to her alcohol, gambling, and smoking addiction. In my treatment plan, I initiated the medication by offering Naltrexone (Vivitrol) 380mg injection intramuscularly through the gluteal region after every four weeks. The client responded positively to the treatment and reported her alcohol addiction. However, she was still struggling with gambling, so I decided to refer her to counseling and support groups to solve her issues related to gambling. Her following assessment showed positive results because she was refraining from gambling. My third decision was to continue her on Naltrexone (Vivitrol) 380mg injection intramuscularly through the gluteal region after every four weeks and solve issues she was facing with her counselor. These measures gave a positive outcome to the patient despite them triggering beneficence and nonmaleficence ethical principles.

References

Bifarin, O., & Stonehouse, D. (2022). Beneficence and nonmaleficence: collaborative practice and harm mitigation. British Journal of Healthcare Assistants, 16(2), 70-74. https://doi.org/10.12968/bjha.2022.16.2.70

Mason, B. J., & Heyser, C. J. (2021). Alcohol use disorder: The role of medication in recovery. Alcohol Research: Current Reviews, 41(1). https://doi.org/10.35946%2Farcr.v41.1.07

Pettorruso, M., Zoratto, F., Miuli, A., De Risio, L., Santorelli, M., Pierotti, A., … & di Giannantonio, M. (2020). Exploring dopaminergic transmission in gambling addiction: A systematic translational review. Neuroscience & Biobehavioral Reviews, 119, 481-511. https://doi.org/10.1016/j.neubiorev.2020.09.034

Solli, K. K., Latif, Z. E. H., Opheim, A., Krajci, P., Sharma‐Haase, K., Benth, J. Š., … & Kunoe, N. (2018). Effectiveness, safety and feasibility of extended‐release Naltrexone for opioid dependence: a 9‐month follow‐up to a 3‐month randomized trial. Addiction, 113(10), 1840-1849. https://doi.org/10.1111/add.14278

Zahid, H., Tsang, B., Ahmed, H., Lee, R. C. Y., Tran, S., & Gerlai, R. (2018). Diazepam fails to alter anxiety-like responses but affects motor function in a white-black test paradigm in larval zebrafish (Danio rerio). Progress in Neuro-Psychopharmacology and Biological Psychiatry, 83, 127-136. https://doi.org/10.1016/j.pnpbp.2018.01.012

Sample Answer 3 for NURS 6630 Assignment 1: Assessing and Treating Patients With Impulsivity, Compulsivity, and Addiction

Gambling disorder with impulsive behaviors such as alcohol abuse disorder are some of the health problems that psychiatric mental health nurse practitioners (PMHNP) face in their practice. PMHNP utilize their advanced knowledge and skills in patient assessment, planning, and implementation to develop effective plans of addressing such problems in their practice. PMHNPs also explore best practices that can be used to optimize the health outcomes for their patients. The purpose of this paper is to examine a case study of Maria Perez, a 53-year-old client who has been diagnosed with gambling disorder with alcohol abuse disorder. Perez reported that her problems have persisted since she was a teenager when her father died. She has been struggling with alcohol since her 20’s and has been on and off the Alcohol Anonymous group for the last 25 years. The client also reported to have gambling issues since a casino was opened near her home. She gets high during gambling and takes alcohol to calm her during high-stake games. She also has the problem of cigarette smoking and is worried of the harm it could have on her health. Perez reported that she has intentions to abstain from drinking but finds it difficult due to gambling that predisposes her to alcohol intake. She is also worried of her weight gain and money spending habits since she has borrowed $50000 to pay her gambling debts. Therefore, the patient factors that will influence the decisions made by the client include her alcohol intake habits, gambling, obesity, and history of poor participation in Alcohol Anonymous group. The purpose of this paper is therefore to discuss the treatment options for the above patient at various treatment points.

Decision 1

Decision Selected

The selected decision in this stage is Naltrexone (Vivitrol) injection, 380 mg intramuscularly in the gluteal region every 4 weeks.

Why it was Selected?

The decision to administer naltrexone was made with the aim of managing alcohol addiction problem that Perez is experiencing. Vivitrol works as a competitive inhibitor of the alcohol receptors (Ragia & Manolopoulos, 2017). The outcome is the reduced craving for alcohol, hence, a suitable agent for managing addiction. The administration of Vivitrol is anticipated to improve the alchol abuse behaviors as well as the thirst that the client has towards alcohol (Zastrozhin et al., 2019). Vivitrol is also effective for the client since it eliminates the adverse effects of drastic cessation of alcohol intake (Blanco-Gandía & Rodríguez-Arias, 2018).

Why I did not select the other Options?

I did not select the use of antabuse (Disulfram) 250 mg orally daily and Campral (Acamprosate) 666 mg orally three times/day because of some reasons. Antabuse was not selected for the patient because the existing evidence supports its use in patients who have ceased from taking alcohol. The use of the drug in patients who are current users of alcohol may result in side effects such as tachycardia (Shirley et al., 2021). Similar contraindications are also seen in Campral (Antonelli et al., 2018).

What I was hoping to Achieve

I was hoping to assist Perez in overcoming her alcohol addiction problem. I was anticipating that the amount of alcohol taken would decrease gradually, improving her alcohol addiction problem. Naltrexone has a high level of tolerability in alcohol abuse (Ragia & G. Manolopoulos, 2017). As a result, I expected that the patient would report minimal side effects of naltrexone use.

Impact of Ethical Considerations

Ethical considerations may affect the above treatment plan and communication with the client. Perez has right to informed care. She is therefore required to be informed about the indications for the medications. There is also the need to ensure safety in patient care. As a result, treatment that has minimal harm and optimum benefits was selected (Pozgar, 2019).

Decision 2

Selected Decision

The selected decision in this stage is referring the client to a counselor to address gambling issues.

Why I Selected This Decision?

I selected the above decision because it could be seen that naltrexone was effective in causing moderate improvement in the symptoms of alcohol addiction. Perez reported that she has not touched a drop of alcohol since the first injection. The client however reported going to casino and spends a lot of money in gambling. The client also reported some problems with anxiety. An effective treatment plan at this stage is referring the client to a counselor. The need for counseling services is that gambling does not have a recommended medication for its management (divsalar & Mohammadi Zeidi, 2020). Non-pharmacological interventions such as psychotherapy are effective in helping the client develop coping skills for managing gambling (Ede et al., 2020).

Why the Other Options were not Selected?

I did not select the decision to add valium (diazepam) 5 mg orally TID/PRN/anxiety because of its safety concerns. Valium is likely to cause sedation and drowsiness in the client, which may affect her adherence to treatment. Valium also does not treat gambling problem (Ede et al., 2020). I did not select the addition of Chantix (varenicline) 1 mg orally BID because there was no indication for augmenting the treatment. Improvements in symptoms have been achieved using naltrexone (Antonelli et al., 2018).

Expected Outcomes

I made the above decision with the aim of assisting Perez to overcome her gambling problem. I also anticipated her to develop effective coping skills for managing gambling. I also intended to ensure optimum effectiveness of the drugs used in treating addiction problems Perez was experiencing (divsalar & Mohammadi Zeidi, 2020).

How Ethical Considerations May Impact my Treatment Plan and Communication with Patients

The ethical consideration of data integrity might influence the treatment plan for the client in this stage. I have to ensure privacy and confidentiality of Perez’s data is protected. The ethical principles of ensuring benevolence and non-maleficence will also influence the treatment plan. I have to ensure that safe treatment interventions are used to minimize harm to the client (Pozgar, 2019).

Decision 3

Selected Decision

The selected decision is, explore the issue that Mrs. Perez is having with her counselor and encourage her to continue attending the Gamblers Anonymous meetings.

Why I Selected the Decision?

I selected the above decision because counseling appears to have been effective in helping Perez overcome her gambling problem. The client reports that her anxiety has been managed. She also reported to have started attending Gambling Anonymous group and she feels supported. The focus should therefore be placed on ensuring that she continues attending Gamblers Anonymous meetings to learn effective skills of overcoming her gambling behavior. Perez will also get the adequate support that she needs from her participation in the Gamblers Anonymous group since she will learn from others about effective strategies for managing gambling (Şenormancı & Şenormancı, 2018). It is also important to inquire the issues that Perez has with her counselor because it has an effect on the effectiveness of the counseling services. Information on their issues will be used to develop effective strategies for improving her relationship with the counselor.

Why I did not select the Other Options?

I did not select the decision to encourage Perez to continue seeing her current counselor as well as continuing with her Gamblers Anonymous group because it would have worsened the relationship between them. Perez already feels that she does not like her counselor. Encouraging her to continue with the counseling sessions may lead to her withdrawal from the treatment. I did not select the decision to continue with vivitrol because of the increased risk of relapse of addiction symptoms and behaviors (Antonelli et al., 2018).

What I was hoping to Achieve?

I was hoping to achieve further improvement in gambling behaviors of the client. I was also hoping to achieve an improvement in the relationship between Perez and her counselor. I was also hoping to ensure that the client developed effective coping skills from participating in the Gamblers Anonymous group (Şenormancı & Şenormancı, 2018). The above outcomes will have resulted in sustained behavioral change in the client.

Effect of Ethical Considerations on Treatment Plan and Communication with Patients

Perez has the right to accept or decline the recommended treatment plan. PMHNP respect the decisions that clients make. Therefore, Perez decision to decline the recommendation to continue with Gamblers Anonymous meeting would have affected the treatment plan and outcomes. Perez has a right to the provision of care that is associated with minimal harm and optimum benefits (Pozgar, 2019). PMHNP has the responsibility of ensuring the ethical principles of veracity, justice, benevolence and non-maleficence are protected to optimize the treatment outcomes.

Conclusion

The management of gambling disorder with impulsive behaviors such as alcohol addiction may be a challenge in practice due to the lack of pharmacological interventions for gambling. However, the approach that was utilized in addressing the care needs of the patient in this case study appeared to have been effective. The decision to administer naltrexone as the first line of approach was effective. Naltrexone is an effective drug that can be used in the management of alcohol addiction. The drug is recommended for use in individuals that are currently taking alcohol. The drug also facilitates gradual discontinuation of alcohol abuse (Ragia & Manolopoulos, 2017). As a result, I believe I made the right decision in treating Perez’s problem of alcohol addiction.

The second decision was also effective in addressing the care needs of the patient in this case study. The effectiveness of the decision is attributed to the fact that gambling does not have an approved drug for its treatment. The FDA has not approved a pharmacological agent for use in addressing the care needs of patients with gambling disorder (divsalar & Mohammadi Zeidi, 2020). As a result, non-pharmacological interventions such as cognitive behavioral therapy as well as participation in social support programs are effective in improving the treatment outcomes in people with gambling disorder. Non-pharmacological interventions are effective in enabling clients develop coping skills to overcome addictive gambling behaviors. The decision to refer the client for counseling services was therefore effective for the client. The decision to encourage the client to continue attending Gambling Anonymous group was also appropriate because it could facilitate the sustained behavioral change (Şenormancı & Şenormancı, 2018). Ethical principles influenced the decisions that were made for Perez. PMHNPs must ensure that principles such as obtaining informed consent, privacy and confidentiality of data, and ensuring no harm to patients are protected.

References

Antonelli, M., Ferrulli, A., Sestito, L., Vassallo, G. A., Tarli, C., Mosoni, C., Rando, M. M., Mirijello, A., Gasbarrini, A., & Addolorato, G. (2018). Alcohol addiction—The safety of available approved treatment options. Expert Opinion on Drug Safety, 17(2), 169–177. https://doi.org/10.1080/14740338.2018.1404025

Blanco-Gandía, M. C., & Rodríguez-Arias, M. (2018). Pharmacological treatments for opiate and alcohol addiction: A historical perspective of the last 50 years. European Journal of Pharmacology, 836, 89–101. https://doi.org/10.1016/j.ejphar.2018.08.007

divsalar,  shahla, & Mohammadi Zeidi, I. (2020). Effectiveness of group counseling and cognitive behavioral therapy on self-regulation, self-efficacy and the prevalence of internet addiction among students of QUMS [Masters, Qazvin university of medical sciences, Qazvin, Iran]. http://eprints.qums.ac.ir/10046/

Ede, M. O., Omeje, J. C., Ncheke, D. C., Agah, J. J., Chinweuba, N. H., & Amoke, C. V. (2020). Assessment of the Effectiveness of Group Cognitive Behavioural Therapy in Reducing Pathological Gambling. Journal of Gambling Studies, 36(4), 1325–1339. https://doi.org/10.1007/s10899-020-09981-y

Pozgar, G. D. (2019). Legal and Ethical Issues for Health Professionals. Jones & Bartlett Learning.

Ragia, G., & G. Manolopoulos, V. (2017). Personalized Medicine of Alcohol Addiction: Pharmacogenomics and Beyond. Current Pharmaceutical Biotechnology, 18(3), 221–230.

Şenormancı, Ö., & Şenormancı, G. (2018). Cognitive Behavioral Therapy and Clinical Applications. BoD – Books on Demand.

Shirley, D.-A., Sharma, I., Warren, C. A., & Moonah, S. (2021). Drug Repurposing of the Alcohol Abuse Medication Disulfiram as an Anti-Parasitic Agent. Frontiers in Cellular and Infection Microbiology, 0. https://doi.org/10.3389/fcimb.2021.633194

Zastrozhin, M. S., Skryabin, V. Y., Miroshkin, S. S., Bryun, E. A., & Sychev, D. A. (2019). Pharmacogenetics of alcohol addiction: Current perspectives. The Application of Clinical Genetics, 12, 131–140. https://doi.org/10.2147/TACG.S206745